Inventor · disambiguated record
Thomas Jerussi
Also filed as: JERUSSI THOMAS P · JERUSSI THOMAS PATRICK · JERUSSI Thomas
54 granted patents·24 pending applications·969 citations·filing 1986–2020
99Inventor score
Top patents by PatentIndex Score
78 records- 0198US7423179B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2006·Granted Sep 9, 2008·12 cites·6 claims
- 0298US6342496B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 29, 2002·217 cites·19 claims
- 0396US7790772B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2009·Granted Sep 7, 2010·15 cites·6 claims
- 0496US7189715B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2003·Granted Mar 13, 2007·40 cites·16 claims
- 0596US7087785B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2003·Granted Aug 8, 2006·28 cites·56 claims
- 0694US7456173B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2006·Granted Nov 25, 2008·11 cites·6 claims
- 0794US7105699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2005·Granted Sep 12, 2006·18 cites·10 claims
- 0894US6476078B2Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunctionSEPRACOR INC·Filed 2001·Granted Nov 5, 2002·43 cites·12 claims
- 0993US7589237B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2008·Granted Sep 15, 2009·14 cites·8 claims
- 1093US6489341B1Methods for the treatment of neuroleptic and related disorders using sertindole derivativesSEPRACOR INC·Filed 2000·Granted Dec 3, 2002·55 cites·37 claims
- 1189US6342533B1Derivatives of (−)-venlafaxine and methods of preparing and using the sameSEPRACOR INC·Filed 1999·Granted Jan 29, 2002·44 cites·17 claims
- 1289US6294582B1Methods for treatment of asthma using S-oxybutyninSEPRACOR INC·Filed 2000·Granted Sep 25, 2001·23 cites·16 claims
- 1388US6632827B2Compositions of optically pure (+) norcisaprideSEPRACOR INC·Filed 2001·Granted Oct 14, 2003·22 cites·9 claims
- 1487US6441048B1Methods of treating affective disorders using derivatives of (-)-venlafaxineSEPRACOR INC·Filed 2001·Granted Aug 27, 2002·15 cites·12 claims
- 1587US6339086B1Methods of making and using N-desmethylzopicloneSWPRACOR INC·Filed 2000·Granted Jan 15, 2002·25 cites·33 claims
- 1686US9072699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jul 7, 2015·4 cites·6 claims
- 1786US6197828B1Derivatives of (+)-venlafaxine and methods of preparing and using the sameSEPRACOR INC·Filed 1999·Granted Mar 6, 2001·63 cites·61 claims
- 1885US8134029B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineJERUSSI Thomas·Filed 2010·Granted Mar 13, 2012·7 cites·18 claims
- 1985US6242465B1Compositions of optically pure (+) norcisaprideSEPRACOR INC·Filed 2000·Granted Jun 5, 2001·14 cites·6 claims
- 2084US6780891B2Tramadol analogs and uses thereofSEPRACOR INC·Filed 2002·Granted Aug 24, 2004·20 cites·61 claims
- 2183US8344030B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Jan 1, 2013·3 cites·6 claims
- 2282US10702486B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·0 cites·6 claims
- 2380US7566725B2Imidazo[1,2-A] pyridine anxiolyticsSEPRACOR INC·Filed 2006·Granted Jul 28, 2009·3 cites·7 claims
- 2479US6974837B2Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitorsSEPRACOR INC·Filed 2002·Granted Dec 13, 2005·7 cites·15 claims
- 2579US6911479B2Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (−)-venlafaxineSEPRACOR INC·Filed 2002·Granted Jun 28, 2005·6 cites·15 claims
- 2679US6538034B2Methods of treating or preventing weight gain, obesity, and related disordersFiled 2001·Granted Mar 25, 2003·9 cites·9 claims
- 2779US5739151AMethod for treating emesis and central nervous system disorders using optically pure (+) norcisaprideSEPRACOR INC·Filed 1996·Granted Apr 14, 1998·32 cites·8 claims
- 2877US6620851B2Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofenSEPRACOR INC·Filed 2002·Granted Sep 16, 2003·6 cites·13 claims
- 2977US6331571B1Methods of treating and preventing attention deficit disordersSEPRACOR INC·Filed 1999·Granted Dec 18, 2001·29 cites·4 claims
- 3077US2021046021A1TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINESUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3176US5807541ANSAID/fluoride periodontal compositions and methodsSEPRACOR INC·Filed 1996·Granted Sep 15, 1998·39 cites·2 claims
- 3274US6946464B2Methods of treating and preventing a convulsive stateSEPRACOR INC·Filed 2003·Granted Sep 20, 2005·5 cites·15 claims
- 3374US6339106B1Methods and compositions for the treatment and prevention of sexual dysfunctionSEPRACOR INC·Filed 2000·Granted Jan 15, 2002·7 cites·26 claims
- 3474US6333345B1Methods of using and compositions comprising N-desmethylzolpidemSEPRACOR INC·Filed 2000·Granted Dec 25, 2001·3 cites·31 claims
- 3573US6303145B2(S,R) formoterol methods and compositionsSEPRACOR INC·Filed 1999·Granted Oct 16, 2001·36 cites·17 claims
- 3672US6506753B2Methods of making and using N-desmethylzopicloneSEPRACOR INC·Filed 2001·Granted Jan 14, 2003·4 cites·5 claims
- 3772US6458791B1Methods of treating muscle spasms using N-desmethylzopicloneSEPRACOR INC·Filed 2002·Granted Oct 1, 2002·4 cites·14 claims
- 3871US7148353B2Imidazo[1,2-a] pyridine anxiolyticsSEPRACOR INC·Filed 2004·Granted Dec 12, 2006·5 cites·6 claims
- 3971US7071234B2Methods of treating or preventing erectile dysfunctionSEPRACOR INC·Filed 2003·Granted Jul 4, 2006·3 cites·20 claims
- 4071US6362227B1Methods for the treatment of tinnitus and other disorders using R(−)ketoptofenSEPRACOR INC·Filed 2000·Granted Mar 26, 2002·3 cites·12 claims
- 4170US10328036B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·6 claims
- 4270US5877188AMethods for treating central nervous system disorders using optically pure (+) norcisaprideSEPRACOR INC·Filed 1997·Granted Mar 2, 1999·20 cites·20 claims
- 4369US8269040B2Derivatives of venlafaxine and methods of preparing and using the sameJERUSSI THOMAS P·Filed 2003·Granted Sep 18, 2012·3 cites·2 claims
- 4467US9072700B2Methods of using derivatives of (−)-venlafaxineSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·0 cites·6 claims
- 4567US6114356AMethod for treating gastrointestinal disorders using (+) norcisaprideSEPRACOR INC·Filed 1998·Granted Sep 5, 2000·17 cites·22 claims
- 4666US9907764B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 4766US8658700B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Feb 25, 2014·0 cites·6 claims
- 4864US6147093AMethods for treating gastroesophageal reflux diseaseSEPRACOR INC·Filed 1998·Granted Nov 14, 2000·13 cites·19 claims
- 4963US2008132578A1Dosage forms of O-desmethylvenlafaxineSEPRACOR INC·Filed 2008·Application pending·0 cites
- 5062US9498452B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Nov 22, 2016·0 cites·6 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →